This study shows multiple sclerosis (MS) costs over $3 billion annually, driven by rising prevalence. MS is a chronic, incurable neurological disease that imposes growing social and economic burdens. The report provides recommendations for government with a focus on improving care, access and research.

This webpage contains a guide for employers and a guide for employees with Multiple Sclerosis (MS). The guide for employers contains information about MS and employing people with MS. The guide for employees contains information about disclosing MS to an employer, management of symptoms at work and implications for career pathways.

New findings from this research report show that while the number of Australians living with Multiple Sclerosis (MS) continues to rise – now at 25,600 – the course of the disease is shifting, with more people able to stay in work and needing less care and support as a result of changes in treatment strategies.